https://www.selleckchem.com/products/nps-2143.html
Joint variation of price and treatment effect size can help assess the cost-effectiveness of a potential Alzheimer's disease treatment.An anticancer drug, cisplatin (CDDP) conjugated gold nanoparticles (GNPs) via L-Lysine (Lys) linker exhibiting a significant toxicity against cancer cells. The produced nanodrug (GNPs-Lys-CDDP) was charachterized by UV-Vis spectroscopy, dynamic light scattering (DLS), Zeta potentials and electron force microscopy. The cytotoxic efficacy of the GNPs-Lys-CDDP against human breast cancer cells (SKBR3) and
Like
Comment
Share
